Global epidemiology of cirrhosis—aetiology, trends and predictions

DQ Huang, NA Terrault, F Tacke, LL Gluud… - Nature reviews …, 2023 - nature.com
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …

Global burden of hepatitis B virus: current status, missed opportunities and a call for action

YC Hsu, DQ Huang, MH Nguyen - Nature Reviews Gastroenterology & …, 2023 - nature.com
Chronic hepatitis B virus (HBV) infection affects about 296 million people worldwide and is
the leading aetiology of cirrhosis and liver cancer globally. Major medical complications also …

Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer …

RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren… - The Lancet, 2023 - thelancet.com
Background Biliary tract cancers, which arise from the intrahepatic or extrahepatic bile ducts
and the gallbladder, generally have a poor prognosis and are rising in incidence worldwide …

[HTML][HTML] Screening and testing for hepatitis B virus infection: CDC recommendations—United States, 2023

EE Conners - MMWR. Recommendations and Reports, 2023 - cdc.gov
Chronic hepatitis B virus (HBV) infection can lead to substantial morbidity and mortality.
Although treatment is not considered curative, antiviral treatment, monitoring, and liver …

New approaches to chronic hepatitis B

G Dusheiko, K Agarwal, MK Maini - New England Journal of …, 2023 - Mass Medical Soc
New Approaches to Chronic Hepatitis B | New England Journal of Medicine Skip to main content
The New England Journal of Medicine homepage Advanced Search SEARCH SPECIALTIES …

2021 American College of Rheumatology guideline for the treatment of rheumatoid arthritis

L Fraenkel, JM Bathon, BR England… - Arthritis & …, 2021 - Wiley Online Library
Objective To develop updated guidelines for the pharmacologic management of rheumatoid
arthritis. Methods We developed clinically relevant population, intervention, comparator, and …

Evidence-based clinical practice guidelines for Liver Cirrhosis 2020

H Yoshiji, S Nagoshi, T Akahane, Y Asaoka… - Journal of …, 2021 - Springer
The first edition of the clinical practice guidelines for liver cirrhosis was published in 2010,
and the second edition was published in 2015 by the Japanese Society of Gastroenterology …

Yttrium‐90 radioembolization for the treatment of solitary, unresectable HCC: the LEGACY study

R Salem, GE Johnson, E Kim, A Riaz, V Bishay… - Hepatology, 2021 - journals.lww.com
Conclusions Despite clear relationships between HBV RNA and HBcrAg levels and CHB
phases, these markers have limited additional value in differentiating CHB phases because …

Why we need a deeper understanding of the pathophysiology of long COVID

A Iwasaki, D Putrino - The Lancet Infectious Diseases, 2023 - thelancet.com
The most recent estimate of people living with post-COVID-19 condition (also known as long
COVID) globally has surpassed 65 million1 and, without clear diagnostic or treatment …

Metabolic dysfunction-associated fatty liver disease and incident cardiovascular disease risk: a nationwide cohort study

H Lee, Y Lee, SU Kim, HC Kim - Clinical Gastroenterology and Hepatology, 2021 - Elsevier
Background & Aims An international expert panel proposed a new definition for metabolic
dysfunction–associated fatty liver disease (MAFLD) as a name change from nonalcoholic …